Оптимізація лікування хворих на діабетичну нефропатію в поєднанні з гіпертонічною хворобою з урахуванням їх клініко-патогенетичних особливостей

134. Hansson L. Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial / L. Hansson, A. Zanchetti, S.G. Carruthers // HOT Study Group. Lancet. - 1998. - 13. - Vol. 351 (9118). - Р. 1755-1762.

135. Hatanaka E. Neutrophils and monocytes as potentially important sources of proinflammatory cytokines in diabetes / E. Hatanaka, P.T. Monteagudo, M.S. Marrocos, A. Campa // Clin. Exp. Immunol. - 2006. - Vol. 146. - P. 443-447.

136. Haumer M. Association of neutrophils and future cardiovascular events in patients with peripheral artery disease / M. Haumer, J. Amighi, M. Exner, W. Mlekusch // J. Vasc. Surg. - 2005. - Vol. 41. - Р. 610-617.

137. Haviarova Z. Expression of Constitutive Nitric Oxide Synthase Isoforms in Varicose Vein Wall; Preliminary Results / Z. Haviarova, A. Janegova, P. Janega, S. Durdэk // Int. J.of Vasc. Med. - 2011. - ID 204723. - 6 p.

138. Hirata F. High glucose exacerbates neutrophil adhesion to human retinal endothelial cells / F. Hirata, M. Yoshida, Y. Ogura // Exp. Eye Res. - 2006. - Vol. 82. - Р. 179-182.

139. Hoang H.H. L-arginine, tetrahydrobiopterin, nitric oxide and diabetes / H.H. Hoang, S.V. Padgham, C.J. Meininger // Curr. Opin. Clin. Nutr. Metab. Care. - 2013. - Vol. 16, № 1. - Р. 76-82.

140. Hodgson K.A. Impaired Early Cytokine Responses at the Site of Infection in a Murine Model of Type 2 Diabetes and Melioidosis Comorbidity / K.A. Hodgson, B.L. Govan, A.K. Walduck // Infection and Immunity. - 2013. - Vol. 81. - Р. 470-477.

141. Hollenberg N.K. Plasma aldosterone concentration in the patient with diabetes mellitus / N.K. Hollenberg, R. Stevanovic, A. Agarwal // Kidney International. - 2004. - Vol. 65. - Р. 1435-1439.

142. Hoorn E.J. A case of primary aldosteronism revealed after renal transplantation / E.J. Hoorn, D.A. Hesselink, M.M. Kho // Nat. Rev. Nephrol. - 2011. - Vol. 7, № 1. - Р. 55-60.

143. Hou F.F. Renoprotection of Optimal Antiproteinuric Doses (ROAD) Study: a randomized controlled study of benazepril and losartan in chronic renal insufficiency / F.F. Hou, D. Xie, X. Zhang // J. Am. Soc. Nephrol. - 2007. - Vol. 18. № 6. - Р. 1889-1898.

144. Imtiaz F. Neutrophil lymphocyte ratio as a measure of systemic inflammation in prevalent chronic diseases in Asian population // Int. Arch. Med. - 2012. - Vol. 5, № 1. - Р. 2-7.

145. Israili Z.H. Metabolic syndrome: treatment of hypertensive patients / Z.H. Israili, B. Lyoussi, R. Hernбndez-Hernбndez // Am J Ther. - 2007. - Vol. 14, 4. - Р. 386-402.

146. Jabіoсski J. The influence of human neutrophils on N-nitrosodimethylamine (NDMA) synthesis / J. Jabіoсski, E. Jabіoсska, J. Iwanowska // Immunopharmacol. Immunotoxicol. - 2006. - Vol. 28, № 1. - Р. 93-102.

147. Jefic D. The prevalence of primary aldosteronism in diabetic patients / D. Jefic, N. Mohiuddin, R. Alsabbagh // J. Clin. Hypertens. (Greenwich). - 2006 - Vol. 8. - № 4. - 253-256.

148. Jiangguo Z. Diabetes mellitus and the neutrophil to lymphocyte ratio predict overall survival in non?viral hepatocellular carcinoma treated with transarterial chemoembolization / Z. Jiangguo, G. Fengyun, L. Ling // Oncology Letters. - 2014. - № 7. - Р. 1704-1710.

149. Jin U.H. Inhibitory effect of Panax notoginseng on nitric oxide synthase, cyclooxygenase-2 and neutrophil functions / U.H. Jin, S.G. Park, S.J. Suh // Phytother. Res. - 2007. - Vol. 21, № 2. - Р. 142-148.

150. Jude E.B. Effect of L-arginine on the microcirculation in the neuropathic diabetic foot in Type 2 diabetes mellitus: a double-blind, placebo-controlled study / E.B. Jude, C. Dang, A.J. Boulton // Diabet Med. - 2010. - Vol. 27, № 1. - Р. 113-116.

151. Juliana C. Infections in patients with diabetes mellitus: A review of pathogenesis /C. Juliana, C. Janine, A. Cresio // Indian J. Endocrinol. Metab. - 2012. - Vol. 16, № 11. - P. 27-36.

152. Kaczmarek M. Whole blood neutrophil chemiluminescence in children with diabetes depending on their clinical condition // Centr. Eur. J. Immunol. - 2012. - № 37 (4). - P. 345-349.

153. Kahraman C. Neutrophil-to-lymphocyte ratio in diabetes mellitus patients with and without diabetic foot ulcer / C. Kahraman, Y. Gьndьz, K.K. Nilьfer, D.N. Nazli // Eur. J. Med. Sci. - 2014. - Vol. 1, № 1. - Р. 8-13.

154. Kalupov T. Structural characterization of mouse neutrophil serine proteases and identification of their substrate specificities: relevance to mouse models of human inflammatory diseases // J. Biol. Chem. - 2009. - Vol. 284. - Р. 34084-34091.

155. Kanwar Y.S. Diabetic nephropathy: mechanisms of renal disease progression / Y.S. Kanwar, J. Wada, L. Sun // Exp. Biol. Med. - 2008. - Vol. 233. - Р. 6-10.

156. Karima M. Enhanced superoxide release and elevated protein kinase C activity in neutrophils from diabetic patients: association with periodontitis / M. Karima, A. Kantarci, T. Ohira // Journal of Leukocyte Biology. - 2005. -Vol. 78. - № 4. - Р. 862-870.

157. Kasama T., Miwa Y., Isozaki T. Neutrophil-derived cytokines: potential therapeutic targets in in?ammation / T. Kasama, Y. Miwa, T.Isozaki // Curr. Drug Targets In?amm. Allergy. - 2005. - № 4. - Р. 273-279.

158. Kent J.W. Intercellular Adhesion Molecule-1 Concentration Is Genetically Correlated With Insulin Resistance, Obesity, and HDL Concentration in Mexican Americans / J.W. Kent, A.G. Comuzzie, M.C. Mahaney, L. Almasy // Diabetes. - 2004. - Vol. 53. - P. 2691-2695.

159. Kewcharoenwong C. Glibenclamide reduces pro-inflammatory cytokine production by neutrophils of diabetes patients in response to bacterial infection / C. Kewcharoenwong, R. Darawan, U. Kusumawadee. - 2013. - № 3. - Р. 1-6.

160. Khosla N. Predictors of Hyperkalemia Risk following Hypertension Control with Aldosterone Blockade / N. Khosla, R. Kalaitzidis, G. Bakris // Am. J. Nephrol. - 2009. - Vol. 30. - Р. 418-424.

161. Kidney Disease: Improving Global Outcomes (KDIGO) Blood Pressure Work Group. KDIGO Clinical Practice Guideline for the Management of Blood Pressure in Chronic Kidney Disease // Kidney inter., Suppl. - 2012. - № 2. - Р. 337-414.

162. Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group. KDIGO 2012 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease // Kidney inter., Suppl. - 2013. - № 3. - 1-150.

163. Konoshita T. Tissue gene expression of rennin-angiotensin system in human type 2 diabetic nephropathy / T. Konoshita, S. Wakahara // Diabetes Care. - 2006. - Vol. 29. - Р. 848-852.

164. Lauer T. L-arginine preferentially dilates stenotic segments of coronary arteries thereby increasing coronary flow / T. Lauer, P. Kleinbongard, J. Rath // J. Intern. Med. - 2008 - Vol. 264, № 3. - Р. 237-244.

165. Lecube A. Phagocytic Activity Is Impaired in Type 2 Diabetes Mellitus and Increases after Metabolic Improvement / A. Lecube, G.Pachуn, J. Petriz, C. Hernбndez // PLoS ONE. - 2011. - Vol. 6 - № 8 - P. 36-39.

166. Ley K. Getting to the site of inflammation: the leukocyte adhesion cascade updated / K. Ley, C. Laudanna, M.I. Cybulsky // Nat. Rev. Immunol. - 2007. - Vol. 7. - Р. 678-689.

167. Ley K., Zarbock A. Hold on to your endothelium: postarrest steps of the leukocyte adhesion cascade / K. Ley, A. Zarbock // Immunity. - 2006. - № 25. - Р. 185-187.

168. Li P. Functional heterogeneity of CD11c-positive adipose tissue macrophages in diet-induced obese mice // J. Biol. Chem. - 2010. - № 285. - Р. 15333-15345.

169. Lomakina E.B. Waugh Adhesion Between Human Neutrophils and Immobilized Endothelial Ligand Vascular Cell Adhesion Molecule 1: Divalent Ion Effects / E.B. Lomakina, E. Richard // Biophysical J. - 2009. - Vol. 96. - Р.276-284.

170. Looney M.R. Neutrophil sandwiches injure the microcirculation / M.R. Looney, M.A. Matthay // Nat. Med. - 2009. - № 15. - Р. 364 -366.

171. Lubos E. Role of oxidative stress and nitric oxide in atherothrombosis / Lubos E., Handy D.E., Loscalzo J. // Front. Biosci. - 2009. - № 13. - Р. 5323-5344.

172. Luo B.H. Structural basis of integrin regulation and signaling / B.H. Luo, C.V. Carman, T.A Springer // Annu Rev Immunol. - 2007. - № 25. - Р. 619-647.

173. Mancia G. Practice guidelines for the management of arterial hypertension of the European Society of Hypertension (ESH) and the European Society of Cardiology (ESC): ESH/ESC Task Force for the Management of Arterial Hypertension / G. Mancia, R. Fagard, K. Narkiewicz // J Hypertens. - 2013 - Vol. 31. - № 10. - Р. 1925-1938.

174. Mann J. Avosentan for Overt Diabetic Nephropathy / J. Mann, D. Green, K. Jamerson // J. Am. Soc. Nephrol. - 2010. - № 21. - Р. 527-535.

175. Mann J. Renal outcomes with telmisartan, ramipril, or both in people at high vascular risk (the ONTARGET study): a multicentre, randomized, double-blind, controlled trial / Mann J., Schmieder R. // Lancet. - 2008. - № 372. - Р. 547-553.

176. Mantovani A. Neutrophils in the activation and regulation of innate and adaptive immunity / A. Mantovani, M.A. Cassatella, C. Costantini // Nat. Rev. Immunol. - 2011. - № 11. - Р. 519-531.

177. Marsland A.L. Systemic inflammation and the metabolic syndrome among middle-aged community volunteers / A.L. Marsland, J.M. McCaffery, M.F. Muldoon // Metabolism - 2010. - № 59. - Р. 1801-1808.

178. Mastej K. Neutrophil surface expression of adhesion molecule CD11b in patients with type 2 diabetes / K. Mastej, R. Adamiec // Przegl. Lek. - 2009. - 66(5). - P. 228-232.

179. Mastej K. Neutrophil surface expression of CD11b and CD62L in diabetic microangiopathy / K. Mastej, R. Adamiec // Acta Diabetol. - 2008. - Vol. 45. - № 3. - P. 183-190.

180. Matsuguma K. Molecular Mechanism for Elevation of Asymetric Dimethylarginine and Its Role for Hypertension in Chronic Kidney Disease / K. Matsuguma, S. Ueda, S. Yamagashi // J. Am. Soc. Neph. - 2006. - № 17. - Р. 2176-2183.

181. Mauer M. Renal and Retinal Effects of Enalapril and Losartan in Type 1 Diabetes / M. Mauer, B. Zinman, R. Gardiner // Engl. J. Med. - 2009. - № 361. - Р. 40-51.

182. Mazzone T. Cardiovascular disease risk in type 2 diabetes mellitus: insights from mechanistic studies / T. Mazzone, A. Chait, J. Plutzky // Lancet. - 2008. - № 371. - Р. 1800-1809.

183. McGill J.B. Improving microvascular outcomes in patients with diabetes through management of hypertension // Postgrad. Med. - 2009. - Vol. 121, № 2. - Р. 89-101.

184. Mehdi U. Addition of Angiotensin Receptor Blocker or Mineralocorticoid Antagonism to Maximal Angiotensin-Converting Enzyme Inhibition in Diabetic Nephropathy / U. Mehdi, B. Adams-Huet // JASN. - 2009. - № 20. - Р. 2641-2650.

185. Mitsuke Y. Nitric oxide synthase activity in peripheral PMN leukocytes in patients with chronic CHF / Y. Mitsuke, J.D. Lee, H. Shimizu // Am. J Cardiol. - 2011. - Vol. 87, № 2. - Р. 183-187.

186. Mogensen C.E. Long-term antihypertensive treatment inhibiting progression of diabetic nephropathy // BMJ. - 1982. - Vol. 285. - Р. 685-688.

187. Montecucco F. Common inflammatory mediators orchestrate pathophysiological processes in rheumatoid arthritis and atherosclerosis. Rheumatology / F. Montecucco, F. Mach // Oxford. - 2009. - № 48. - Р. 11-22.

188. Muniyappa R. Insulin Action and insulin resistance in vascular endothelium / R. Muniyappa, M. Quon // Curr. Op. Nutr. Metab. Care. - 2007. - Vol. 10. - Р. 523.

189. Nabi A.H. Polymorphonuclear Neutrophil Dysfunctions in Streptozotocin-induced Type 1 Diabetic Rats / A.H. Nabi, N.I. Laila, R.M. Mahfuzur // Journal of Biochemistry and Molecular Biology. - 2005. - Vol. 38. - № 6. - Р. 661-667.

190. Nathan C. Neutrophils and immunity: challenges and opportunities. // Nat. Rev. Immunol. - 2006 - Vol. 6. - Р. 173-182.

191. National Kidney Foundation KDOQI Clinical Practice Guidelines and Clinical Practice Recommendations for Diabetes and Chronic Kidney Disease // Am. J. Kidney Dis. - 2007. - Vol. 49(suppl 2). - Р. 1-180.

192. National Kidney Foundation. KDOQI Clinical Practice Guideline for Diabetes and CKD: 2012 update // Am. J. Kidney Dis. - 2012. - Vol. 60, № 5. - Р. 850-886.

193. Niedowicz D.M. The role of oxidative stress in diabetic complications / D.M. Niedowicz, D.L. Daleke // Cell Biochem. Biophys. - 2005 - Vol. 43, № 2. -Р. 289-330.

194. Nielsen S.E. Neutrophil Gelatinase-Associated Lipocalin (NGAL) and Kidney Injury Molecule 1 (KIM1) in patients with diabetic nephropathy: a cross-sectional study and the effects of lisinopril / S.E. Nielsen, K.J. Schjoedt, A.S. Astrup // Diabet. Med. - 2010. - Vol. 27, № 10. - Р. 1144-1150.

195. Nolan S. Nitric Oxide Regulates Neutrophil Migration through Microparticle Formation / S. Nolan, R. Dixon, K. Norman, P. Hellewell // American Journal of Pathology. - 2008. - Vol. 172. - Р. 265-273.

196. Nunes S. The role of inflammation in diabetic cardiomyopathy / S. Nunes, E. Soares, F. Pereira, F. Reis // International Journal of Interferon, Cytokine and Mediator Research. - 2012. - № 4. - Р. 59-73.

197. Nurun A.H.M. Polymorphonuclear Neutrophil Dysfunctions Streptozotocin-induced Type 1 Diabetic Rats / A.H.M Nurun // Journal of Biochemistry and Molecular Biology. - 2005. - № 6. - P. 661-667.

198. Ogawa S. Angiotensin II Type 1 Receptor Blockers Reduce Urinary Oxidative Stress Markers in Hypertensive Diabetic Nephropathy / S. Ogawa, T. Mori // HTN. - 2006. - № 47. - Р. 699-705.

199. Ohkita М. Drug discovery for overcoming chronic kidney disease (CKD): the endothelin ETB receptor / nitric oxide system functions as a protective factor in CKD / Ohkita М., Takaoka М., Matsumura Y. // J. Pharmacol. Sci. - 2009. - №109. - Р. 7-13.

200. Oka R.K. A pilot study of L-arginine supplementation on functional capacity in peripheral arterial disease / R.K. Oka, A. Szuba, J.C. Giacomini // Vasc. Med. - 2005. - Vol.10, № 4. - Р. 265-274.

201. Omori K. Priming of neutrophil oxidative burst in diabetes requires preassembly of the NADPH oxidase / Omori K., Ohira T., Uchida Y. // J. Leukoc. Biol. - 2008. - Vol. 84, № 1. - Р. 292-301.

202. Parving H.H. Diabetic Nephropathy / H.H. Parving, M. Mauer, E. Ritz - 7th еd. - Philadelphia; Saunders, 2004. - 818 р.

203. Patel J.D. iNOS-mediated generation of reactive oxygen and nitrogen species by biomaterial-adherent neutrophils / J.D. Patel, T. Krupka, J.M. Anderson // J. Biomed. Mater. Res. A. - 2007. - Vol. 80, № 2. - Р. 381-390.

204. Patel A. Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes/ A. Patel, S. MacMahon, J. Chalmers // N. Engl. J. Med. - 2008. - Vol. 358. - Р. 2560-2572.

205. Paul M. Physiology of local renin-angiotensin systems / M. Paul, A.P. Mehr, R. Kreutz // Physiol. Rev. - 2006. - Vol. 86, № 3. - Р. 747-803.

206. Persson F. Renal Effects of Aliskiren Compared With and in Combination with Irbesartan in patients with Type 2 Diabetes, Hypertension and Albuminuria / F. Persson, P. Rossing, H. Reinhard // Diabetes Care. - 2009. - № 32. - Р. 1873-1879.

207. Pham C.T. Neutrophil serine proteases: specific regulators of inflammation // Nat. Rev. Immunol. - 2006. - № 6. - Р. 541-550.

208. Piga R. Short-term high glucose exposure induces monocyte-endothelial cells adhesion and transmigration by increasing VCAM-1 and MCP-1 expression in human aortic endothelial cells / R. Piga, Y. Naito, S. Kokura, O. Handa // Atherosclerosis. - 2007. - Vol. 193. - Р. 328-334.

209. Pisarczyk-Wiza D. Increase in glycaemia stimulates reactive oxygen species (ROS) production by polymorphonuclear neutrophils in type 2 diabetic patients / D. Pisarczyk-Wiza, D. Zozuliсska-Ziуіkiewicz, H.Wysocki // Journal of Pre-Clinical and Clinical Research. - 2011. - Vol. 5. - Р. 22-27.

210. Prabhakar S. Diabetic Nephropathy is Associated with Oxidative Stress and Decreased Renal Nitric Oxide Production / S. Prabhakar, J. Starnes, S. Shi // J. Am. Soc. Neph. - 2007. - № 18. - Р. 2945-2952.

211. Rajapakse N.W. Insulin-mediated activation of the L-arginine nitric oxide pathway in man, and its impairment in diabetes / N.W. Rajapakse, A.L. Chong, W.Z. Zhang, D.M. Kaye // PLoS One. - 2013. - Vol.8, № 5. - e61840.

212. Rossing K. Beneficial Effects of Adding Spironolactone to Recommended Antihypertensive Treatment in Diabetic Nephropathy // K. Rossing, K.J. Schjoedt, U. M. Smidt // Diabetes Care. - 2005. - Vol. 28. - Р. 2106-2112.

213. Ruilope L.M. The kidney and cardiovascular risk -- implications for management: a consensus statement from the European Society of Hypertension / L.M. Ruilope, S.E. Kjeldsen, A. de la Sierra // Blood Pressure. - 2007. - Vol. 16, № 2. - Р. 72-79.

214. Rydell-Tormanen K. Neutrophil cannibalism--a back up when the macrophage clearance system is insufficient / K. Rydell-Tormanen, L. Uller, J. S. Erjefalt // Respir. Res - 2006. - № 7. - Р. 143-144.

215. Saiepour D. Hyperglycemia-Induced Protein Kinase C Activation Inhibits Phagocytosis of C3b- and Immunoglobulin G-Opsonized Yeast Particles in Normal Human Neutrophils / D. Saiepour, J. Sehlin, P.-A. Oldenborg // Experimental Diab. Res. - 2003. - Vol. 4. - P. 125-132.

216. Saito Y. The influence of blood glucose on neutrophil function in individuals without diabetes / Y. Saito, I. Takahashi, K. Iwane, N. Okubo // Luminescence. - 2013. - Vol. 28, Issue 4. - Р. 569-573.

217. Santos R.A. Recent advances in the angiotensin-converting enzyme 2-angiotensin(1-7)-Mas axis / R.A. Santos, A.J. Ferreira, A.C. Simхes e Silva // Exp. Physiol. - 2008 - Vol. 93, № 5. - Р. 519-527.

218. Saswata T. Neutrophils mediate insulin resistance in mice fed a high-fat diet through secreted elastase / T. Saswata // Nature Medicine. - 2012. - № 10. - P. 1038-1045.

219. Schjoedt K. Beneficial impact of spironolactone on nephritic range albuminuria in diabetic nephropathy / K. Schjoedt, K. Rossing, T. Juhl // Kidney International. - 2006. - Vol. 70. - Р. 36-42.

220. Schjoedt K. Optimal dose of lisinopril for renoprotection in type 1 diabetic patients with diabetic nephropathy: a randomised cross-over trial / K. Schjoedt, A.S. Astrup, F. Persson // Diabetologia. - 2009. - Vol. 52, №1. - Р. 46-49.

221. Schlaich M.P. Effects of nitric oxide synthase inhibition and L-arginine on renal haemodynamics in young patients at high cardiovascular risk / M.P. Schlaich, S. Oehmer, M.P. Schneider // Atherosclerosis. - 2007. - Vol. 192, 1. - Р. 155-160.

222. Schulze F. L-Arginine enhances the triglyceride-lowering effect of simvastatin in patients with elevated plasma triglycerides / F. Schulze, S. Glos, D. Petruschka // Nutr. Res. - 2009. - Vol. 29, № 5. - Р. 291-297.

223. Segel G.B. The paradox of the neutrophil's role in tissue injury / G.B. Segel, M.W. Halterman // J. Leukoc. Biol. - 2011. - Vol. 89. - Р. 359-372.

224. Selcuk H. The relation between differential leukocyte count, neutrophil to lymphocyte ratio and the presence and severity of coronary artery disease / H. Selcuk, L. Dinc, M.T. Selcuk, O. Maden // Open Journal of Internal Medicine. - 2012. - Vol. 2. - Р. 163-169.

225. Selter M. Wide spread tissue distription and changes in activity of Ca2+ -dependent NO-synthase / M. Selter, R.G. Knowles, S. Moncada // FEBS Lett. - 1991. - Vol. 291, № 1. - P.145-149.

226. Shelton J.L. Inducible NO synthase (iNOS) in human neutrophils but not pulmonary microvascular endothelial cells (PMVEC) mediates septic protein leak in vitro / J.L. Shelton, L. Wang, G. Cepinskas // Microvasc. Res. - 2007. - Vol. 74. - № 1. - Р. 23-31.

227. Shetty A. Comparison of Mean Platelet Volume, Platelet Count, Total Leucocyte and Neutrophil Counts in Normoglycemics, Impaired Fasting Glusose and Diabetics / A. Shetty, C. Vijaya, V.J. Jayalakshmi // International Journal of Scientific Study. - 2014. - Vol. 2, Issue 2. - Р. 24-27.

228. Silva M.T. Neutrophils and macrophages work in concert as inducers and effectors of adaptive immunity against extracellular and intracellular microbial pathogens // Journal of Leukocyte Biology. - 2010. - Vol. 87. - Р. 805-813.

229. Soehnlein O. An elegant defense: how neutrophils shape the immune response // Trends Immunol. - 2009. - № 9. - Р. 78-84.

230. Sokup A. Adhesion molecules in type 2 diabetes // Przegl. Lek. - 2005. -Vol. 62, № 4. - Р. 234-237.

231. Song, H. Expression of CD18 on the neutrophils of patients with diabetic retinopathy / H. Song, L. Wang, Y. Hui // Graefes Arch. Clin. Exp. Ophthalmol. - 2007. - Vol. 245. - Р. 24-31.

232. Stamler J. The Multiple Risk Factor Intervention Trial (MRFIT)--Importance Then and Now / J. Stamler, J.D. Neaton // JAMA. - 2008. - Vol. 300, № 11. - Р. 1343-1345.

233. Stegenga M.E. Hyperglycemia enhances coagulation and reduces neutrophil degranulation, whereas hyperinsulinemia inhibits fibrinolysis during human endotoxemia / M.E. Stegenga, S.N. van der Crabben, R. M. E. Blumer // Blood. - 2008. - Vol. 112. - Р. 82-89.

234. Sud M. Presentation blood glucose and death, hospitalization, and future diabetes risk in patients with acute heart failure syndromes / Sud M., Wang X., Austin P.C. // Eur. Heart J. - 2015. - Vol. 62. - Р. 85-91.

235. Sudo C. Clinical significance of neutrophil apoptosis in peripheral blood of patients with type 2 diabetes mellitus / C. Sudo, H. Ogawara, A.W. Saleh // Lab. Hematol. - 2007. - № 13 (3). - P. 108-12.

236. Susztak K. Glucose-induced reactive oxygen species cause apoptosis of podocytes and podocyte depletion at the onset of diabetic nephropathy / K. Susztak, A.C. Raff, M. Schiffer, E.P. Bцttinger // Diabetes. - 2006. - Vol. 55, № 1. - Р. 225-233.

237. Talukdar D.S. Neutrophils mediate insulin resistance in mice fed a high-fat diet through secreted elastase / Talukdar D.S. Young O., Gautam B. // Nature Medicine. - 2012. - Vol. 34, № 3. - Р. 27-33.

238. The ACCORD Study Group. Effects of Intensive Blood Pressure Control in type 2 Diabetes Mellitus // N. Engl. J. Med. - 2010. - № 362. - Р. 1575-1585.

239. Tsang J.L. Regulation of apoptosis and priming of neutrophil oxidative burst by diisopropyl fluorophosphates / J.L. Tsang, J.C. Parodo, J.C. Marshall // Journal of Inflammation. - 2010. - № 7. - Р. 32-38.

240. Turina M. Effects of hyperglycemia, hyperinsulinemia, and hyperosmolarity on neutrophil apoptosis / M. Turina, F.N. Miller, C. Tucker // Surg. Infect. (Larchmt). - 2006. -Vol. 7, № 2. - Р. 111-121.

241. Tuttle K.R. Linking Metabolism and Immunology: Diabetic Nephropathy Is an Inflammatory Disease // J. Am. Soc. Nephrol. - 2005. - № 16. - Р. 1537-1538.

242. Van Buren P.N. Hypertension in Diabetic Nephropathy: Epidemiology, Mechanisms, and Management / P.N. Van Buren, R. Toto // Adv. Chronic Kidney Dis. - 2011. - Vol. 18, № 1. - Р. 28-41.

243. Van Buren P.N. Current update in the management of diabetic nephropathy / P.N. Van Buren, R. Toto // Curr. Diabetes Rev. - 2013. - Vol. 9, № 1. - Р. 62-77.

244. Van de Wal R. Determinants of increased angiotensin II levels in severe chronic heart failure patients despite ACE inhibition / R.Van de Wal, T. Plokker, D. Lok // Int. Cardiol. - 2006. -Vol. 106. - Р. 367-372.

245. Van Gisbergen K.P. Close encounters of neutrophils and DCs / K.P. van Gisbergen, T.B. Geijtenbeek, Y. van Kooyk // Trends Immunol. - 2005. - Vol. 26. - Р. 626-631.

246. Verdecchia P. Evidence for cardiovascular, cerebrovascular, and renal protective effects of renin-angiotensin system blockers / P. Verdecchia, G. Gentile, F.F. Angeli / Ther. Adv. Cardiovasc. Dis. - 2012. - Vol. 6, № 2. - Р. 81-91.

247. Voisin M-B. Monocytes and Neutrophils Exhibit Both Distinct and Common Mechanisms in Penetrating the Vascular Basement Membrane In Vivo / M-B. Voisin, A. Woodfin, S. Nourshargh // Arterioscler. Thromb. Vasc. Biol. - 2009. -Vol. 29, № 8. - Р. 1193-1199.

248. Wai B. Beta blocker use in subjects with type 2 diabetes mellitus and systolic heart failure does not worsen glycaemic control / B. Wai, L.G. Kearney, D.L. Hare // Cardiovasc. Diabetol. - 2012. - № 11. - Р. 14-19.

249. Wei X. Correlation between Peripheral White Blood Cell Counts and Hyperglycemic Emergencies / X. Wei, W. Haifeng, M. Shaogang // Int. J. Med. Sci. - 2013. - Vol. 10, № 6. - Р. 758-765.

250. Williams T.M. Macrophages in renal development, injury, and repair / T.M. Williams, M.H. Little, S.D. Ricardo // Semin. Nephrol. - 2010. - Vol. 30, № 3. - P. 255-267.

251. Woodfin A. Recent developments and complexities in neutrophil transmigration / A. Woodfin, M-B. Voisin, S. Nourshargh // Curr. Opin. Hematol. - 2010. -Vol. 17, № 1. - Р. 9-17.

252. Wu T. Cardiovascular disease in diabetic nephropathy patients: cell adhesion mole-cules as potential markers? / T. Wu, K.C. McGrath, A.K. Death // Vasc. Health Risk Manag. - 2005. - Vol. 1, № 4. - P. 309-316.

253. Yang D. Alarmins link neutrophils and dendritic cells / D. Yang, G. de la Rosa, P. Tewary // Trends Immunol. - 2009. - № 7. - Р. 65-69.

254. Yano H. Insulin treatment directly restores neutrophil phagocytosis and bactericidal activity in diabetic mice, thereby improving surgical site infection with Staphylococcus aureus / H. Yano, M. Kinoshita, K. Fujino // Infect. Immun. - 2012. - Vol. 80, № 12. - P. 4409-4416.

255. Yoneda T. Aldosterone breakthrough during angiotensin II receptor blockade in hypertensive patients with diabetes mellitus / T. Yoneda, Y. Takeda, M. Usukura // Am. J. Hypertens. - 2007. - №9. - P. 49-54.

256. Yonekawa K. Targeting leukocyte integrins in human diseases / K. Yonekawa, J.M. Harlan // J. Leukoc. Biol. - 2005. - Vol. 77. - Р. 129-140.

257. Zarbock A. Spleen tyrosine kinase Syk is necessary for E-selectin-induced aLв2 integrin (LFA-1)-mediated rolling on intercellular adhesion molecule-1 (ICAM-1) / A. Zarbock, C. Lowell, K. Ley // Immunity. - 2007. - Vol. 26. - Р. 773-783.

258. Zarbock A. Mechanisms and Consequences of Neutrophil Interaction with the Endothelium / A. Zarbock, K. Ley // American Journal of Pathology. - 2008. - Vol. 172. - Р. 1-7.

259. Zemans R.L. Transepithelial Migration of Neutrophils: Mechanisms and Implications for Acute Lung Injury / R.L. Zemans, S.P. Colgan, G.P. Downey // Am. J. Respir. Cell Mol. Biol. - 2009. - Vol. 40, № 5. - Р. 519-535.

260. Zillich A. Thiazide Diuretics, Potassium, and the Development of Diabetes: a Quantitative Review / A. Zillich, J. Garg, S. Basu // HTN. - 2006. - Vol. 48. -Р. 219-224.

261. Zola H. CD molecules 2005: human cell dif-ferentiation molecules / H. Zola, B. Swart, I. Nicholson // Blood. - 2005. - Vol. 106. - Р. 3123-3126.

Размещено на Allbest.ru